IS SHORT-TERM ACYCLOVIR TREATMENT RELATED WITH MORE UNFAVOURABLE OUTCOMES IN PATIENTS WITH HSV-1 ENCEPHALITIS?

Ferhat Arslan, Ravza Akgündüz, Abdülkadir Ermiş, Begüm Bektaş, Ebru Erbayat, Haluk Vahaboğlu
doi: https://doi.org/10.1101/2022.02.08.22270584

Article Information

doi 
https://doi.org/10.1101/2022.02.08.22270584
History 
  • February 10, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Ferhat Arslan1,*,
  2. Ravza Akgündüz1,
  3. Abdülkadir Ermiş2,
  4. Begüm Bektaş1,
  5. Ebru Erbayat2 and
  6. Haluk Vahaboğlu1
  1. 1Department of Infectious Diseases, Istanbul Medeniyet University, Faculty of Medicine, Istanbul,Turkey
  2. 2Department of Neurology, Istanbul Medipol University, Faculty of Medicine, Istanbul,Turkey
  1. ↵*Corresponding author
    : Ferhat Arslan, Associate Professor, Email addresses
    : ferhatarslandr{at}hotmail.com, Department of Infectious Diseases, Istanbul Medeniyet University, Faculty of Medicine, Prof. Dr. Süleyman Yalcın Training and Research Hospital, Kadıköy, Istanbul
Back to top
Posted February 10, 2022.
Download PDF
Data/Code
Email
IS SHORT-TERM ACYCLOVIR TREATMENT RELATED WITH MORE UNFAVOURABLE OUTCOMES IN PATIENTS WITH HSV-1 ENCEPHALITIS?
Ferhat Arslan, Ravza Akgündüz, Abdülkadir Ermiş, Begüm Bektaş, Ebru Erbayat, Haluk Vahaboğlu
medRxiv 2022.02.08.22270584; doi: https://doi.org/10.1101/2022.02.08.22270584
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area